Delivery Order 36F79723D0136-36C26124N0528
- Not listed
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business. The contract, valued at $10,530.00, is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the Puget Sound VA Medical Center. The contract has an ultimate completion date of December 21, 2023. Amylyx Pharmaceuticals holds several significant indefinite delivery...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business, for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The contract, valued at $44,459.84, was awarded on January 6, 2023, with a completion date of January 31, 2023. Amylyx holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $93,599.60 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract is for the delivery of RELYVRIO SODIUM PHENYLBUTYRATE to support VHA programs. Amylyx will provide the pharmaceutical product to multiple VA medical centers in the region from November 2023 through January 2024. No subcontractors...
- Amylyx Pharmaceuticals Inc. was awarded a $46,799.80 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The order, issued without a set-aside designation, has a period of performance through May 1, 2024 for delivery to a location in Cambridge, Massachusetts. Amylyx holds several federal vehicles that facilitate provision of its pharmaceutical...
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVIO. The contract has a period of performance from July 13, 2023 through September 13, 2023 and will be performed in Cambridge, Massachusetts. VHA VISN 21 oversees healthcare services for veterans in northern New England. This delivery order...
- This federal contract award is for "EMERGENCY LYMYRZ" and was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency. The contract was awarded to Avadel CNS Pharmaceuticals, LLC, a for-profit, foreign-owned organization, on September 22, 2025 as a Firm Fixed Price Delivery Order with a ceiling value of $11,197.82 and a completion date of September 30, 2025. The contract is not set aside and is under the Pharmaceuticals and Drugs Federal Supply Schedule...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 12, to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract is for the supply of Dalfampridine 10mg sustained-action tablets, a medication used to treat multiple sclerosis. The firm fixed-price contract has a ceiling value of $861,948.00 and a performance period ending on March 15, 2016. Acorda Therapeutics holds several...
- This is a $534,397 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Trillamed LLC, a service-disabled veteran-owned small business, for the provision of AMYVID radiopharmaceutical. The contract has no set-aside designation and has an ultimate completion date of October 18, 2024. Trillamed is a prime contractor that also serves as a subcontractor to Cardinal Health, providing medical/surgical equipment and supplies to federal agencies. The company has multiple...
- <p>This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a civilian agency, to Avadel CNS Pharmaceuticals, LLC, a for-profit foreign-owned organization. The contract is for the product PHARM - LUMRYZ and has a ceiling value of $160,366.92. The ultimate completion date is September 30, 2026. The contract is not set aside. It is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle.</p>
- 36F79723D0136Federal Supply Schedule
- 36F79723D0136-36C26124N0528Delivery Order
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Amylyx Pharmaceuticals Inc. for the provision of the drug RELYVRIO, which contains the active ingredients sodium phenylbutyrate and taurursodiol. The contract has a potential value of $93,599.60 and a completion date of April 20, 2024. Amylyx, a self-certified small disadvantaged business, has provided RELYVRIO to the VA through multiple federal contracts, including a $50,000 blanket purchase agreement with the VA National Acquisition Center. This delivery order is part of Amylyx's larger federal contract portfolio, which includes Federal Supply Schedule contracts and other indefinite-delivery vehicles for hematology products and drugs/pharmaceuticals. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.6k | 3/20/24 |